IRIDEX Corporation
General ticker "IRIX" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $20.7M (TTM average)
IRIDEX Corporation follows the US Stock Market performance with the rate: 12.6%.
Estimated limits based on current volatility of 5.7%: low 1.31$, high 1.47$
Factors to consider:
- Total employees count: 111 (-14.6%) as of 2023
- US accounted for 50.2% of revenue in the fiscal year ended 2023-12-30
- Top business risk factors: Economic downturns and volatility, Geopolitical risks, Product defects, IT system disruptions, Labor/talent shortage/retention
- Price in estimated range
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.08$, 2.62$]
- 2025-12-31 to 2026-12-31 estimated range: [1.05$, 2.54$]
Financial Metrics affecting the IRIX estimates:
- Positive: with PPE of -3.1 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -26.47 <= 0.04
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Industry inventory ratio change (median), % of -1.22 <= -0.18
- Negative: Shareholder equity ratio, % of 7.20 <= 19.35
Short-term IRIX quotes
Long-term IRIX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $56.97MM | $51.87MM | $48.67MM |
| Operating Expenses | $64.51MM | $61.88MM | $56.97MM |
| Operating Income | $-7.54MM | $-10.01MM | $-8.30MM |
| Non-Operating Income | $0.06MM | $0.53MM | $-0.54MM |
| R&D Expense | $7.17MM | $6.83MM | $5.45MM |
| Income(Loss) | $-7.48MM | $-9.48MM | $-8.84MM |
| Taxes | $0.07MM | $0.09MM | $0.07MM |
| Profit(Loss)* | $-7.55MM | $-9.57MM | $-8.91MM |
| Stockholders Equity | $17.23MM | $9.52MM | $2.10MM |
| Inventory | $10.61MM | $9.91MM | $10.82MM |
| Assets | $42.29MM | $34.44MM | $29.14MM |
| Operating Cash Flow | $-9.52MM | $-6.75MM | $-7.29MM |
| Capital expenditure | $0.29MM | $0.11MM | $0.01MM |
| Investing Cash Flow | $-0.29MM | $-0.11MM | $-0.01MM |
| Financing Cash Flow | $-0.07MM | $-0.01MM | $2.60MM |
| Earnings Per Share** | $-0.47 | $-0.59 | $-0.54 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.